Not unusual for NOAC users to revert to warfarin
One in every 20 patients who switch from warfarin to a non-vitamin K antagonist oral anticoagulant (NOAC) is likely to switch back again, Australian data suggests.
A retrospective study of patients enrolled in a warfarin program at a private pathology practice in Queensland showed that more than 3000 patients switched from warfarin to a NOAC between 2012 and 2017.
But 4.7% of these patients switched back to warfarin, and most (61%) reverted within six months of being put on a NOAC, the authors said.
A GP’s advice to change drugs was the stated reason why